Haematological improvement as a beneficial effect during deferasirox treatment in transfusion-dependent patients with myelodysplastic syndrome

被引：6
|
作者：
Molica, Matteo [1 ]
Salaroli, Adriano [1 ]
Alimena, Giuliana [1 ]
Breccia, Massimo [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
BLOOD TRANSFUSION | 2014年 / 12卷
关键词：
D O I：
10.2450/2013.0005-13
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [31] Remission of transfusion-dependent myelodysplastic syndrome in association with respiratory tract infection
    Philip T. Murphy
    Michael Fay
    John Quinn
    J. Rory O’Donnell
    Annals of Hematology, 2005, 84 : 614 - 615
  • [32] Predictors of cardiovascular events and all-cause of death in patients with transfusion-dependent myelodysplastic syndrome
    Alonso-Fernandez-Gatta, Marta
    Martin-Garcia, Ana
    Martin-Garcia, Agustin C.
    Lopez-Cadenas, Felix
    Diaz-Pelaez, Elena
    Jimenez-Solas, Tamara
    Gonzalez-Martinez, Teresa
    Sanchez-Pablo, Clara
    Diez-Campelo, Maria
    Sanchez, Pedro L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (04) : 536 - 541
  • [33] Deferasirox Efficacy and Safety for the Treatment of Transfusion-Dependent Iron Overload in Patients with a Range of Rare Anemias.
    Porter, John B.
    Lin, Kai-Hsin
    Habr, Dany
    Domokos, Gabor
    Hmissi, Abdel
    Thein, Swee Lay
    BLOOD, 2008, 112 (11) : 506 - 506
  • [34] Health-Related Quality Of Life In Transfusion-Dependent Patients With Myelodysplastic Syndromes Treated With Deferasirox. A Multicenter Prospective Study
    Efficace, Fabio
    Santini, Valeria
    La Nasa, Giorgio
    Cottone, Francesco
    Finelli, Carlo
    Borin, Lorenza
    Quaresmini, Giulia
    Di Tucci, Anna
    Volpe, Antonio
    Cilloni, Daniela
    Quarta, Giovanni
    Sanpaolo, Grazia
    Rivellini, Flavia
    Salvi, Flavia
    Molteni, Alfredo
    Vallisa, Daniele
    Storti, Sergio
    Voso, Maria Teresa
    Alimena, Giuliana
    Fenu, Susanna
    Vignetti, Marco
    Mandelli, Franco
    Angelucci, Emanuele
    BLOOD, 2013, 122 (21)
  • [35] Deferasirox (Exjade®) Is Effective and Well Tolerated in Chelation-Naive and Previously Chelated Patients with Transfusion-Dependent Myelodysplastic Syndromes (MDS)
    Schmid, Mathias
    Guerci-Bresler, Agnes
    Della Porta, Matteo
    Taylor, Kerry
    Habr, Dany
    Domokos, Gabor
    Roubert, Bernard
    Rose, Christian
    Gattermann, Norbert
    BLOOD, 2009, 114 (22) : 1464 - 1464
  • [36] Efficacy and safety of iron chelator for transfusion-dependent patients with myelodysplastic syndrome: a meta-analysis
    Zhang, JingLing
    Shi, Pengchong
    Liu, Jin
    Li, Jinggang
    Cao, Yingping
    HEMATOLOGY, 2019, 24 (01) : 669 - 678
  • [37] Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
    Musto, Pellegrino
    Maurillo, Luca
    Simeon, Vittorio
    Poloni, Antonella
    Finelli, Carlo
    Balleari, Enrico
    Ricco, Alessandra
    Rivellini, Flavia
    Cortelezzi, Agostino
    Tarantini, Giuseppe
    Villani, Oreste
    Mansueto, Giovanna
    Milella, Maria R.
    Scapicchio, Daniele
    Marziano, Gioacchino
    Breccia, Massimo
    Niscola, Pasquale
    Sanna, Alessandro
    Clissa, Cristina
    Voso, Maria T.
    Fenu, Susanna
    Venditti, Adriano
    Santini, Valeria
    Angelucci, Emanuele
    Levis, Alessandro
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (05) : 741 - 750
  • [38] Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic
    Santini, Valeria
    Giagounidis, Aristoteles
    Pelligra, Christopher G.
    Franco-Villalobos, Conrado
    Tang, Derek
    Morison, Jessica
    Beach, Cl
    Hu, Angela
    Platzbecker, Uwe
    Fenaux, Pierre
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (09): : E874 - E883
  • [39] Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
    Bordbar, Mohammad Reza
    Silavizadeh, Samir
    Haghpanah, Sezaneh
    Kamfiroozi, Roza
    Bardestani, Marzieh
    Karimi, Mehran
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (06)
  • [40] SEVERE RENAL, HEPATIC AND GASTROINTESTINAL EVENTS ASSOCIATED WITH DEFERASIROX IN PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA
    Huang, W. F.
    Hsiao, F. Y.
    Chou, H. C.
    Tsai, Y. W.
    Yen, H. C.
    Ke, W. M.
    VALUE IN HEALTH, 2011, 14 (03) : A59 - A59
12345